Tuya Pal

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Mary B. Daly, Tuya Pal, Michael P. Berry et al. · Journal of the National Comprehensive Cancer Network · 2021 · 1.1K citations · Full text

Medicine, Genetics, Oncology +17

A Population-Based Study of Genes Previously Implicated in Breast Cancer

Chunling Hu, Steven N. Hart, Rohan Gnanaolivu et al. · New England Journal of Medicine · 2021 · 866 citations · Full text

Medicine, Genetics, Molecular Genetics +17

<i>BRCA1</i> and <i>BRCA2</i> mutations account for a large proportion of ovarian carcinoma cases

Tuya Pal, Jenny Permuth‐Wey, Judith A. Betts et al. · Cancer · 2005 · 691 citations

Life Sciences, Genetics, Oncology +14

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017

Mary B. Daly, Robert Pilarski, Michael P. Berry et al. · Journal of the National Comprehensive Cancer Network · 2016 · 661 citations · Full text

Life Sciences, Genetics, Oncology +17

Genetic/Familial High-Risk Assessment: Breast and Ovarian

Mary B. Daly, Jennifer E. Axilbund, Saundra S. Buys et al. · Journal of the National Comprehensive Cancer Network · 2010 · 650 citations · Full text

Life Sciences, Genetics, Oncology +17